Status:
COMPLETED
Pleth Variability Index in Pulmonary Embolism
Lead Sponsor:
Suleyman Demirel University
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18-93 years
Brief Summary
Pulmonary embolism(PE) is a ventilation/perfusion disorder caused by obstruction of the pulmonary artery, usually by a thrombus. The Pleth Variability Index(PVI) is a continuous, noninvasive indicator...
Detailed Description
Pulmonary embolism(PE) is a ventilation/perfusion disorder caused by obstruction of the pulmonary artery, usually by a thrombus. The Pleth Variability Index(PVI) is a continuous, noninvasive indicator...
Eligibility Criteria
Inclusion
- To be over 18 years old
- Diagnosis of pulmonary embolism
Exclusion
- patients had asthma and chronic obstructive pulmonary disease exacerbation
- patients had acute decompensated heart failure
- patients were pregnant
- patient was under 18 years old
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06508112
Start Date
April 1 2023
End Date
June 1 2024
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suleyman Demirel University Faculty of Medicine
Isparta, Turkey (Türkiye), 32260